DHL Global Forwarding is elevating its capabilities in Asia Pacific’s life science and healthcare sector by introducing a dual-certified cold chain facility in Malaysia. This facility, situated within the Kuala Lumpur International Airport Free Commercial Zone, spans 38,000 square feet and is the first of its kind to be certified for both 15-25°C and 2-8°C storage. With prestigious certifications like DHL Air GxP and IATA CEIV Pharma, this cutting-edge facility ensures unparalleled flexibility and regulatory compliance for pharmaceutical logistics customers.
The DHL Air GxP certification, aligned with the World Health Organization’s guidelines, sets a high standard for quality and compliance across DHL’s pharmaceutical stations. Complementing this, the IATA CEIV Pharma certification recognizes DHL’s proficiency in handling time- and temperature-sensitive pharmaceutical shipments. As the market in Malaysia is poised to grow significantly, DHL’s Managing Director for Singapore, Malaysia, and Brunei, Praveen Gregory, emphasizes the strategic importance of the region as a hub for medical technology companies.
To maintain the integrity of the cold chain and ensure top-notch service, DHL deploys a team of dedicated Life Sciences Specialists who undergo continuous training to meet evolving industry standards and regulatory requirements. The company’s commitment to sustainability is reflected in the facility’s design, featuring eco-friendly materials and energy-efficient systems. DHL’s forward-looking approach includes plans for mobile freezer units and an expanded service portfolio encompassing frozen commodities like vaccines and industrial chemicals.
In the dynamic landscape of healthcare logistics, Asia Pacific is emerging as a pivotal region for innovation and distribution. DHL, recognizing this trend, has strategically positioned itself with a robust cold chain network across the region. Through its dedicated “DHL Health Logistics” sector brand and significant investments in Life Sciences infrastructure, DHL is at the forefront of supporting the industry’s growth and ensuring seamless logistics operations. With multiple certified stations and a suite of integrated supply chain solutions, DHL is equipped to meet the demanding requirements of pharmaceutical logistics.
As DHL continues to invest in sustainable growth and operational excellence, it remains a reliable partner for life sciences companies seeking resilient and future-ready logistics solutions. With a strong presence in key Asian hubs and a focus on innovation and compliance, DHL is poised to lead the way in ensuring safe, efficient, and sustainable delivery of critical healthcare products to patients across Asia Pacific.
Takeaways:
– DHL’s dual-certified cold chain facility in Malaysia sets new standards for pharmaceutical logistics in Asia Pacific.
– The company’s focus on training Life Sciences Specialists and sustainable practices underscores its commitment to quality and compliance.
– DHL’s strategic investments in healthcare logistics infrastructure position it as a key player in supporting the region’s pharmaceutical industry growth.
– With a strong emphasis on innovation, compliance, and sustainability, DHL is a preferred logistics partner for life sciences companies in Asia Pacific.
Tags: clinical trials, regulatory
Read more on manilatimes.net